Acute renal failure in systemic sclerosis revealing Goodpasture syndrome: “All that glitters is not scleroderma renal crisis”

The most common cause of acute renal failure in systemic sclerosis patients is scleroderma renal crisis but other etiologies have to be considered such as another autoimmune disease. We report the case of a 60-year-old male admitted to our hospital with a renal failure. His medical history included a diagnosis of systemic sclerosis 6 months ago. Antinuclear antibodies were positive at a titer of 1:1280 with positive anti-Scl-70 and anti-myeloperoxidase (34 U/mL) antibodies. Scleroderma renal crisis was suspected. However, antineutrophil cytoplasmic antibody–associated vasculitis could not be excluded and a renal biopsy was performed. Histopathology revealed crescentic glomerulonephritis and rupture of Bowman’s capsule. Anti-glomerular basement membrane antibodies were detected in serum and the diagnosis of Goodpasture syndrome was confirmed by kidney’s immunofluorescence analysis showing typical deposits. Only three other cases of systemic sclerosis associated with Goodpasture syndrome have been reported in the literature. Also, rapidly progressive glomerulonephritis with positivity of both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibodies has been described. Several studies have suggested that antineutrophil cytoplasmic antibody positivity occurs first leading to damages of the glomerular basement membrane, to the release of alpha-3 NC1 antigen, and ultimately to anti-glomerular basement membrane antibody production. Although rare, antineutrophil cytoplasmic antibody–associated vasculitis and Goodpasture syndrome should be searched for in systemic sclerosis patients with acute renal failure.

[1]  V. Tesar,et al.  Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients , 2017, Kidney international.

[2]  Min Chen,et al.  Antibodies against linear epitopes on Goodpasture autoantigen in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis , 2017, Clinical Rheumatology.

[3]  Min Chen,et al.  Autoantibodies against Linear Epitopes of Myeloperoxidase in Anti-Glomerular Basement Membrane Disease. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[4]  M. Hudson Scleroderma renal crisis , 2015, Current opinion in rheumatology.

[5]  M. de Vincentiis,et al.  Goodpasture's syndrome: a clinical update. , 2015, Autoimmunity reviews.

[6]  L. Mouthon,et al.  Scleroderma Renal Crisis , 2014, The Journal of Rheumatology.

[7]  C. Denton,et al.  Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors. , 2013, Rheumatology.

[8]  L. Gøransson,et al.  Crescentic glomerulonephritis and microangiopathic haemolytic anaemia in a patient with established systemic sclerosis , 2011, Scandinavian journal of urology and nephrology.

[9]  K. Abbott,et al.  Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease. , 2011, Journal of the American Society of Nephrology : JASN.

[10]  U. Arad,et al.  Anti-neutrophil antibody associated vasculitis in systemic sclerosis. , 2011, Seminars in arthritis and rheumatism.

[11]  Y. Fujioka,et al.  Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases , 2011, Clinical and Experimental Nephrology.

[12]  A. Herrick,et al.  Epidemiology of systemic sclerosis. , 2010, Best practice & research. Clinical rheumatology.

[13]  D. Fulcher,et al.  Development of anti-glomerular basement membrane disease after remission from perinuclear ANCA-associated glomerulonephritis in a patient with HLA susceptibility. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  Y. Lee,et al.  Scleroderma associated with ANCA-associated vasculitis , 2006, Rheumatology International.

[15]  T. Dougan,et al.  Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. , 2004, Kidney international.

[16]  R. Peces,et al.  Sequential development of pulmonary hemorrhage with MPO-ANCA complicating anti-glomerular basement membrane antibody-mediated glomerulonephritis. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  A. Collins,et al.  Comparison of anti-GBM antibodies in sera with or without ANCA. , 1997, Journal of the American Society of Nephrology : JASN.

[18]  Y. Arimura,et al.  [A case of progressive systemic sclerosis with crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) and anti-glomerular basement membrane antibody (anti-GBM Ab)]. , 1995, Nihon Jinzo Gakkai shi.

[19]  H. Kondo,et al.  Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. , 1994, The Journal of rheumatology.

[20]  D. Jayne,et al.  Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. , 1990, Kidney international.

[21]  P. Kristufek,et al.  [Progressive systemic sclerosis (diffuse sclerodermia) and Goodpasture's syndrom in 47-years-old woman (author's transl)]. , 1975, Beiträge zur Klinik und Erforschung der Tuberkulose und der Lungenkrankheiten.

[22]  V. Dornetzhuber,et al.  Progressive Systemsklerose (diffuse Sklerodermie) und Goodpasture'sches Syndrom bei einer 47jährigen Frau , 1975, Pneumonologie.

[23]  T. Uzu,et al.  [Case of scleroderma with rapid progressive glomerulonephritis associated with both MPO-ANCA and anti-GBM antibodies]. , 2008, Nihon Jinzo Gakkai shi.

[24]  V. Steen Scleroderma renal crisis. , 1996, Rheumatic diseases clinics of North America.